摘要
目的观察喘可治注射液联合布地奈德治疗支气管哮喘的临床疗效。方法选择我院2006年11月-2008年11月确诊为支气管哮喘患者104例,随机分为2组,各52例。治疗组52例,常规吸入布地奈德的基础上,加用喘可治注射液;对照组52例,仅给予布地奈德吸入治疗。2组在治疗过程中如合并呼吸道细菌感染,加用抗生素。有哮喘急性发作,可加用β2受体激动剂。观察2组治疗前后夜间憋醒天数、哮喘急性发作的天数、β2受体激动剂应用天数及肺功能情况。结果治疗组总有效率为90.4%,对照组总有效率为69.2%。2组比较差异有统计学意义(P<0.05)。结论喘可治注射液联合布地奈德治疗效果较常规疗效好,可作为糖皮质激素的补充治疗。
Objective To observe the curative effect of Budesonide combined with Chuankezhi injection on bronehial asthma. Methods 104 patients with bronchial asthma diagnosed in 2006 -2008 were randomly selected and divided into 2 groups. 52 eases in the treatment group were treated with Chnankezhi injection on the basis of Budesonide, while 52 eases in the control group were treated with Budesonide. Then improvement of symptom and eorrelative indexes were ovserved before and after treatments. Results The total effective rate in the treatment group was 90.40% versus 69.2% in the control group, and the difference was signifieant（ P 〈 0.05 ）. Conclusion In comparison with routine treatment, Budesonide combined with Chuankezhi injection has a better effeet on bronchial asthma as a supplementary therapy of glueoeortieoid.
出处
《临床合理用药杂志》
2009年第5期14-15,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
支气管哮喘
布地奈德
喘可治
Bronchial asthma
Budesonide
Chuankezhi injection
